DATA

ANALYTICS
ACTIVITY #1
(Critique of a research)

SUBMITTED TO:
Dr. Serena Gomez

SUBMITTED BY:
Canonizado, Julia Louise C.
Batch Valkyrie – 3NU01
Estimating direct medical costs of type 2 diabetes mellitus in the
Philippines: a protocol

 Abstract
Diabetes and its complications are a major cause of morbidity and mortality in
the Philippines. The prevalence of diabetes in the Philippines has increased
from 3.4 million in 2010 to 3.7 million in 2017. The government has
formulated strategies to control this increase, for example, through its non-
communicable disease prevention and control plan. However, there is scarce
research on the financial burden of diabetes. Filling this gap may further help
policymakers to make informed decisions while developing and implementing
resource planning for relevant interventions. The primary objective of the
current study is to estimate the direct medical costs associated with type 2
diabetes mellitus (T2DM).(
Methods and analysis This is a 1-year retrospective cohort study of patients
with T2DM in 2016. Data will be collected from: (1) hospital databases from
public institutions to estimate the cost of diabetes treatment and (2) physician
interviews to estimate the cost of management of diabetes in outpatient care.
We will perform descriptive and comparative analysis on direct medical costs
and healthcare resource utilization, stratified by the presence of diabetes-
associated complications.

Objectives of the study

 To estimate the direct medical costs associated with type 2 diabetes
mellitus (T2DM).
Methods used to gather the data.
 Descriptive and comparative analysis
 Interviews
Sampling and sampling procedure
 A purposive sampling of 50 physicians to achieve the diversity of
institutions/clinics in Metro Manila.
The findings of the study
 The outcome of interest is the mean direct medical costs in patients
with diabetes complications and those without complications.
 Direct medical costs of patients with and without complications will be
estimated.

SOURCES :
https://bmjopen.bmj.com/content/bmjopen/10/7/e025696.full.pdf

If you were to do the same study how would you do it?

If given the chance to conduct the same study, I would like to include
actual diabetic patients to share their own experiences in the costings of their
treatments, because I believe that data from a personal experience and
perspective, for me, would be more legitimate and accurate, since it would not
only include the hospital bills itself, but the expenses in and out of facilities,
and the medication. Hopefully, this would add to the strengths of the study.